Yvon AB

Affärsutveckling/Business Development - Styrelseuppdrag

My Business Idea is to offer qualified consulting, strategic advice in business development and board assignments to Life Science companies through established or revised business- and marketplans, regulatory, financial and economic support.

Since year 2010 I'm cooperating with Hull Associates LLC Medtech Consulting in Boston, USA, as their Nordic expert in reimbursement evaluations in connection with market launch of medical devices. www.hullassociates.com

My Services and Offers:

  • Company evaluations in connection with an investment
  • Financial evaluations in connection with an investment
  • Identification of buyers in connection with a divesture
  • Short and Long term interim and managment positions
  • Creation and revision of Business Plans
  • Creation and revision of Market Plans
  • Mapping of markets and industries
  • Regulatory and Reimbursement advices
  • Board Assignments

Yvonne Petersson has broad international business and marketing experience with more than 20 years within the expansive Life Science industry and more than 10 years in Venture Capital. She has evaluated more than 100’s of early stage high tech innovative companies. Yvonne was just recently Investment Manager at Industrifonden and was previously Investment Manager/Business Developer at Affärsstrategerna.
She started her long international career in early 1980 within Baxter, an international Medtech and Pharmaceutical company, as CFO, Nordic CEO and European Director of Healthcare Economics. Yvonne is executive and non-executive director in a few start-up companies as well as at Umeå Biotech Incubator in Umeå and SLU Holding in Uppsala, Sweden.
Yvonne is consulting in business development to early stage companies within the Life Science industry. This is covering i.e. set up/execution of business and market plans, advice in regulatory and reimbursement strategies, financing and investment support, interim management and coaching. Yvonne is contributing with an approach of commercialization and competence in the field of medical devices, diagnostics, technology platforms, pharmaceuticals and a vast network. Yvonne has a finance degree from University of Lund, Sweden.

Industrifonden provides capital, competence and networks to small and medium sized Swedish com-panies with international growth potential. It invests in companies requiring early-stage and expansion capital in the ICT, Life Science, Industrial Ventures and Cleantech sectors. It has total assets of SEK 2,900 million and holdings in about 100 companies.

Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Revenues of 5,6 billion dollars and approx 49700 employees.

Chemel AB engages in the development, manufacture, and marketing of electrochemical analytical instrumentation. The company’s biosensor product is used in the biotech, food and beverage, pharmaceutical, sugar production, and forest industries. It also offers various accessories, disposables, and replacement products. The company was founded in 1996 and is based in Lund, Sweden.

Affärsstrategerna was founded in 1988 and is one of the first venture capital companies in Sweden. Since then approx. 50 investments have been made in companies of the Life Science, IT and Wireless industry. During the past Affärsstrategerna has shown significant results in industrial trade sales and IPO's. As examples of the latter, Optosof (Mogul), Fingerprint Cards, Megacon, Artimplant, Artema Medical and RaySearch Laboratories. A larger industrial trade sales was the sales of Wireless Solutions to Allgon.